Velmanase alfa for treating alpha-mannosidosis [ID800]: evaluation consultation
We are listening to your views on this Highly specialised technology. Comments close 16 August 2022.
Search results
251 results
-
-
Leriglitazone for treating andrenoleukodystrophy [ID3903]
Awaiting development [GID-HST10049] Expected publication date: TBC
-
OTL-101 for treating adenosine deaminase deficiency–severe combined immunodeficiency [ID1152]
Awaiting development [GID-HST10022] Expected publication date: TBC
-
Lonafarnib for treating progeria and progeroid laminopathies [ID3867]
Awaiting development [GID-HST10039] Expected publication date: TBC
-
VTS-270 for treating Niemann-Pick type C1 (ID1267)
Awaiting development [GID-HST10020] Expected publication date: TBC
-
Asfotase alfa for treating paediatric-onset hypophosphatasia (review of HST6) [ID3927]
Awaiting development [GID-HST10046] Expected publication date: 15 December 2022
-
Palovarotene for preventing heterotopic ossification associated with fibrodysplasia ossificans progressiva [ID3739]
Awaiting development [GID-HST10032] Expected publication date: TBC
-
Laparoscopic insertion of a magnetic titanium ring for gastro-oesophageal reflux disease: interventional procedure consultation
We are listening to your views on this Interventional procedures guidance. Comments close 18 August 2022.
-
Transcutaneous electrical stimulation of the trigeminal nerve for ADHD: interventional procedure consultation
We are listening to your views on this Interventional procedures guidance. Comments close 18 August 2022.
-
Percutaneous image-guided cryoablation of peripheral neuroma for chronic pain: interventional procedure consultation
We are listening to your views on this Interventional procedures guidance. Comments close 18 August 2022.
-
Trabeculectomy with biodegradable collagen matrix implant for glaucoma: interventional procedure consultation
We are listening to your views on this Interventional procedures guidance. Comments close 18 August 2022.
-
TriageHF Plus
Awaiting development [GID-DG10064] Expected publication date: TBC
-
Tucatinib with trastuzumab and capecitabine for treating HER2-positive unresectable locally advanced or metastatic breast cancer after 2 or more anti-HER2 therapies [ID3828]: appraisal consultation
We are listening to your views on this Technology appraisal guidance. Comments close 16 November 2021.
-
Electrosurgery (diathermy and coblation) for tonsillectomy
Awaiting development [GID-IPG10246] Expected publication date: 26 July 2023
-
Intramuscular diaphragm stimulation for ventilator-dependent chronic respiratory failure caused by high spinal cord injuries
Awaiting development [GID-IPG10248] Expected publication date: 22 May 2023
-
Radiofrequency denervation for osteoarthritic knee pain
Awaiting development [GID-IPG10236] Expected publication date: 29 June 2023
-
Endoscopic ultrasound-guided gallbladder drainage for acute cholecystitis
Awaiting development [GID-IPG10235] Expected publication date: 28 June 2023
-
Endoscopic ultrasound guided biliary drainage for malignant obstruction
Awaiting development [GID-IPG10234] Expected publication date: 21 April 2023
-
Intraoperative electron beam radiotherapy for locally advanced and locally recurrent colorectal cancer
Awaiting development [GID-IPG10261] Expected publication date: TBC
-
Vaginal natural orifice transluminal endoscopic surgery for hysterectomy and adnexal surgery
Awaiting development [GID-IPG10240] Expected publication date: 23 August 2023
-
Cryotherapy for Chronic Rhinitis
Awaiting development [GID-IPG10251] Expected publication date: 27 September 2023
-
Transurethral water jet ablation for lower urinary tract symptoms caused by benign prostatic hyperplasia
Awaiting development [GID-IPG10249] Expected publication date: 27 September 2023
-
Targeted temperature management following cardiac arrest to improve neurological
Awaiting development [GID-IPG10238] Expected publication date: 25 May 2023
-
Aortic valve reconstruction with glutaraldehyde-treated autologous pericardium
Awaiting development [GID-IPG10237] Expected publication date: 23 August 2023
-
Electrical stimulation of the pharynx for neurogenic dysphagia
Awaiting development [GID-IPG10212] Expected publication date: 08 March 2023
-
Irreversible electroporation for treating prostate cancer
Awaiting development [GID-IPG10262] Expected publication date: 01 February 2023
-
Insertion of neo-chordae into the beating heart for mitral regurgitation
Awaiting development [GID-IPG10216] Expected publication date: 26 July 2023
-
Middle Meningeal Embolisation for Chronic Subdural Haematomas (CSDH)
Awaiting development [GID-IPG10215] Expected publication date: 26 July 2023
-
Minimally invasive deformity correction system for the treatment of adolescent idiopathic scoliosis
Awaiting development [GID-IPG10247] Expected publication date: 06 July 2023
-
Selective internal radiation therapy for unresectable colorectal metastases in the liver
Awaiting development [GID-IPG10252] Expected publication date: 29 November 2023
-
Carotid artery stent placement for asymptomatic extracranial carotid stenosis
Awaiting development [GID-IPG10250] Expected publication date: 25 October 2023
-
Biodegradable subacromial spacer insertion for rotator cuff tears
Awaiting development [GID-IPG10264] Expected publication date: 25 October 2023
-
Biodegradable spacer insertion to reduce rectal toxicity during radiotherapy for prostate cancer
Awaiting development [GID-IPG10205] Expected publication date: 07 February 2023
-
Balloon disimpaction of the baby's head at emergency caesarean
Awaiting development [GID-IPG10220] Expected publication date: 16 November 2022
-
Transcutaneous electrical stimulation of the supraorbital nerve for treating and preventing migraine
Awaiting development [GID-IPG10175] Expected publication date: 26 October 2022
-
Long term tunneled peritoneal drainage catheter insertion for palliation of refractory ascites in cirrhosis
Awaiting development [GID-IPG10194] Expected publication date: 23 November 2022
-
Daratumumab with lenalidomide and dexamethasone for untreated multiple myeloma when stem cell transplant is unsuitable [ID4014]
Awaiting development [GID-TA10914] Expected publication date: 01 February 2023
-
Sintilimab with pemetrexed and platinum-based chemotherapy for untreated advanced non-squamous non-small-cell lung cancer [ID4050]
Awaiting development [GID-TA10934] Expected publication date: TBC
-
Fordadistrogene movaparvovec for the treatment of Duchenne muscular dystrophy TS ID 10420
Awaiting development [GID-TA11044] Expected publication date: TBC
-
Setmelanotide for treating obesity and hyperphagia in Bardet-Biedl syndrome or Alström syndrome ID3947
Awaiting development [GID-TA10834] Expected publication date: TBC
-
Zamtocabtagene autoleucel for treating relapsed or refractory diffuse large B-cell lymphoma after 2 or more therapies TS ID 10765
Awaiting development [GID-TA11050] Expected publication date: TBC
-
Bimekizumab for treating moderate to severe hidradenitis suppurativa TS ID 10637
Awaiting development [GID-TA11045] Expected publication date: TBC
-
Leniolisib for untreated activated phosphoinositide 3-kinase delta syndrome in people 12 years and over TS ID 10657
Awaiting development [GID-TA11046] Expected publication date: TBC
-
Tislelizumab for untreated unresectable hepatocellular carcinoma TS ID 10683
Awaiting development [GID-TA11053] Expected publication date: TBC
-
Selpercatinib for untreated RET-positive advanced medullary thyroid cancer in people 12 years and over TS ID 10762
Awaiting development [GID-TA11047] Expected publication date: TBC
-
Rucaparib with nivolumab for maintenance treatment of platinum-sensitive advanced ovarian, fallopian tube or peritoneal cancer after 1 therapy TS ID 10763
Awaiting development [GID-TA11048] Expected publication date: TBC
-
Rucaparib for treating hormone-relapsed metastatic prostate cancer with homologous recombination deficiency after 1 therapy TS ID 10764
Awaiting development [GID-TA11049] Expected publication date: TBC
-
Cedazuridine–decitabine for untreated acute myeloid leukaemia unsuitable for intensive chemotherapy TS ID 10605
Awaiting development [GID-TA11051] Expected publication date: TBC
-
REGN5458 for treating relapsed or refractory multiple myeloma TS ID 10443
Awaiting development [GID-TA11052] Expected publication date: TBC
-
Empagliflozin for treating chronic kidney disease TS ID 10698
Awaiting development [GID-TA11043] Expected publication date: TBC